Optimal use of regorafenib: Dosing strategies and patient selection

Axel Grothey

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	8-10
Number of pages	3
Journal	Clinical Advances in Hematology and Oncology
Volume	14
Issue number	3
State	Published - 2016

ASJC Scopus subject areas

@article{b1176a6e0c4f4019951b3ff51719f810,

title = "Optimal use of regorafenib: Dosing strategies and patient selection",

author = "Axel Grothey",

year = "2016",

language = "English (US)",

volume = "14",

pages = "8--10",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "3",

}

TY - JOUR

T1 - Optimal use of regorafenib

T2 - Dosing strategies and patient selection

AU - Grothey, Axel

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=85010377728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010377728&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:85010377728

SN - 1543-0790

VL - 14

SP - 8

EP - 10

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 3

ER -